Provider review

Henry Meds semaglutide review

Henry Meds semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.

Illustration of bottles and boxes lined up on a shelf

Updated 2026-09-18 · Public-source editorial · See dated evidence below


Henry Meds prices compounded semaglutide by format, and the spread is wide enough that the advertised figure and the one you pay can differ by more than a hundred dollars a month.

The weekly injection runs about $297 a month. Sublingual is around $249, with a $179 tier available. The $179 is the number in the advertising. No membership is charged on any of them, which is a genuine point in Henry’s favour.

Recorded costs and what to confirm

Comparison stepSemaglutide at Henry Meds
Earlier figuresDated cost record
TreatmentName the product, route, prescribed amount and supply period
First paymentItemize medicine, care, tests, supplies and delivery
RenewalGive the next charge, its date and the supply it covers
Change or exitExplain remaining charges and any refund before payment

The $179 tier is sublingual. The weekly injection is around $297/month.

At $297 a month, twelve months of the recorded Henry injectable offer total $3,564, against $948 on the twelve-month Coreage Rx semaglutide plan. The prepaid oral route is a different formulation and commitment.

How Henry Meds works

Compounded GLP-1 provider with a strong oral and sublingual line alongside weekly injections, sold in monthly and prepaid multi-month blocks.

The sublingual and oral lines are the reason to be here. Three-month oral semaglutide is $747, or $537 paid in full, which brings the monthly figure down to about $179 — competitive, provided the format suits you. Clinical support is solid and the company has been around long enough to have a track record.

The earlier source record

  • Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
  • Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
  • Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
  • Three-month oral tirzepatide supply $1,047, or $891 paid in full.
  • Three-month oral semaglutide supply $747, or $537 paid in full.
  • Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.

Where it is strong

  • No membership fee layered on top of medication.
  • Real choice of sublingual, oral tablet and injection.
  • Discounts for paying a multi-month block up front.

Where it falls short

  • Recurring injectable tirzepatide at $449/month is the most expensive compounded option here.
  • The "$179" and "$297" figures describe different products, which readers routinely conflate.
  • Month one and month two prices differ by $50.

The thing most people miss

The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

How it scored

The historical rubric gives Henry Meds 3 out of 5. Display position 19 of 19 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.

What we weighWeightScore
True monthly cost30%2.3 / 5
Price honesty20%2.8 / 5
Clinical support20%3.7 / 5
Pharmacy sourcing15%3.6 / 5
Cancelling15%2.9 / 5

Who it suits

Suits needle-averse patients and anyone happy to prepay a quarter up front. Does not suit someone who wants the weekly injection at the lowest price.

Our verdict

Buy the oral or sublingual product here, or buy the injection somewhere cheaper. Read carefully which one you are being quoted.

How it compares on semaglutide

The full reasoning behind this order is in our best semaglutide providers guide.

Read next

Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure